Back to top

Barclays Sticks to Their Sell Rating for Pfizer (PFE)

Barclays analyst Emily Field maintained a Sell rating on Pfizer today and set a price target of $25.00. Field covers the Healthcare sector, focusin...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Pfizer Inc. (PFE)